NCT07096791View on ClinicalTrials.gov

A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

April 30, 2027

Conditions
Postpartum Depressive Disorder
Interventions
DRUG

KH607 tablet

oral，once daily for 14 days

DRUG

placebo

oral，once daily for 14 days

Sponsors
All Listed Sponsors
lead

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT07096791 - A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression | Biotech Hunter | Biotech Hunter